MOMETASONE FUROATE MONOHYDRATE

N/A

Manufactured by CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED

1,126 FDA adverse event reports analyzed

Last updated: 2026-04-15

About MOMETASONE FUROATE MONOHYDRATE

MOMETASONE FUROATE MONOHYDRATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED. The most commonly reported adverse reactions for MOMETASONE FUROATE MONOHYDRATE include DEATH, NAUSEA, DRUG INEFFECTIVE, DIARRHOEA, FATIGUE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for MOMETASONE FUROATE MONOHYDRATE.

Top Adverse Reactions

DEATH81 reports
NAUSEA33 reports
DRUG INEFFECTIVE30 reports
DIARRHOEA25 reports
FATIGUE25 reports
PAIN25 reports
HEADACHE23 reports
EXPOSURE TO TOXIC AGENT22 reports
MALAISE22 reports
PRURITUS20 reports
DYSPNOEA19 reports
RASH19 reports
ANXIETY18 reports
ARTHRALGIA18 reports
ASTHENIA17 reports
PALPITATIONS17 reports
DIZZINESS16 reports
COUGH15 reports
PAIN IN EXTREMITY15 reports
SINUSITIS15 reports
CONDITION AGGRAVATED14 reports
FALL14 reports
FEELING ABNORMAL14 reports
MUSCULOSKELETAL STIFFNESS14 reports
RHEUMATOID ARTHRITIS14 reports
ASTHMA13 reports
PYREXIA13 reports
VOMITING13 reports
BURSITIS12 reports
ENTHESOPATHY12 reports
MUSCLE SPASMS12 reports
OFF LABEL USE12 reports
ORAL PAIN12 reports
STOMATITIS12 reports
TENOSYNOVITIS12 reports
WEIGHT INCREASED12 reports
INSOMNIA11 reports
MIGRAINE11 reports
PARAESTHESIA11 reports
SOMNOLENCE11 reports
URTICARIA11 reports
DEPRESSION10 reports
HYPERSENSITIVITY10 reports
INJECTION SITE PAIN10 reports
NASOPHARYNGITIS10 reports
ABDOMINAL PAIN UPPER9 reports
BLOOD PRESSURE INCREASED9 reports
CONSTIPATION9 reports
NASAL CONGESTION9 reports
PSORIASIS9 reports
THERAPEUTIC RESPONSE UNEXPECTED9 reports
WEIGHT DECREASED9 reports
BACK PAIN8 reports
DEHYDRATION8 reports
ERYTHEMA8 reports
FEELING HOT8 reports
FLUSHING8 reports
INTENTIONAL PRODUCT USE ISSUE8 reports
OVERDOSE8 reports
TREMOR8 reports
URINARY TRACT INFECTION8 reports
ACNE7 reports
CONFUSIONAL STATE7 reports
DECREASED APPETITE7 reports
GAIT DISTURBANCE7 reports
HYPERTENSION7 reports
HYPOAESTHESIA7 reports
NEUROPATHY PERIPHERAL7 reports
PNEUMONIA7 reports
ABDOMINAL DISCOMFORT6 reports
CHILLS6 reports
HOT FLUSH6 reports
HYPERHIDROSIS6 reports
MUSCULAR WEAKNESS6 reports
OEDEMA PERIPHERAL6 reports
PRE EXISTING CONDITION IMPROVED6 reports
RHINORRHOEA6 reports
SKIN BURNING SENSATION6 reports
VISION BLURRED6 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS6 reports
CHEST DISCOMFORT5 reports
CHEST PAIN5 reports
DISORIENTATION5 reports
DRY SKIN5 reports
DYSPHONIA5 reports
GASTROOESOPHAGEAL REFLUX DISEASE5 reports
INJECTION SITE PRURITUS5 reports
LETHARGY5 reports
MEMORY IMPAIRMENT5 reports
OROPHARYNGEAL PAIN5 reports
PAIN OF SKIN5 reports
PERIPHERAL SWELLING5 reports
SWELLING5 reports
THROAT IRRITATION5 reports
ABDOMINAL PAIN4 reports
ANAEMIA4 reports
ANGIOEDEMA4 reports
ARTHROPATHY4 reports
BALANCE DISORDER4 reports
BLOOD GLUCOSE INCREASED4 reports

Report Outcomes

Out of 501 classified reports for MOMETASONE FUROATE MONOHYDRATE:

Serious 58.7%Non-Serious 41.3%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female332 (69.0%)
Male149 (31.0%)

Reports by Age

Age 5918 reports
Age 4512 reports
Age 6112 reports
Age 629 reports
Age 528 reports
Age 638 reports
Age 547 reports
Age 557 reports
Age 336 reports
Age 416 reports
Age 436 reports
Age 536 reports
Age 656 reports
Age 686 reports
Age 706 reports
Age 726 reports
Age 225 reports
Age 275 reports
Age 345 reports
Age 365 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with MOMETASONE FUROATE MONOHYDRATE?

This profile reflects 1,126 FDA FAERS reports that mention MOMETASONE FUROATE MONOHYDRATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for MOMETASONE FUROATE MONOHYDRATE?

Frequently reported terms in FAERS include DEATH, NAUSEA, DRUG INEFFECTIVE, DIARRHOEA, FATIGUE, PAIN. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures MOMETASONE FUROATE MONOHYDRATE?

Labeling and FAERS entries often list CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED in connection with MOMETASONE FUROATE MONOHYDRATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.